Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases.

Abstract

Infections, including opportunistic infections, are a major and frequent cause of morbidity and mortality in patients with systemic autoimmune and rheumatic diseases. Pneumocystis jirovecii pneumonia, classically considered to be typical of HIV patients, transplanted patients or patients treated with oncological chemotherapy, is appearing increasingly frequently in these patients. Therefore, rheumatologists should know its mechanism of production, clinical manifestations, treatment and prophylaxis, all of which are addressed in this review.

• Authors: Paloma Vela Casasempere, Paloma Ruiz Torregrosa, Raquel García Sevila
• Journal: Reumatologia clinica (Reumatol Clin (Engl Ed)) Vol. 17 Issue 5 Pg. 290-296 (May 2021) ISSN: 2173-5743 [Electronic] Spain
• Vernacular Title: Pneumocystis jirovecii en pacientes inmunocomprometidos con enfermedades reumáticas.
• PMID: 32466869 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.